A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL)
Clinical trial NCT06594679 · RECRUITING
Trial details
- NCT number
- NCT06594679
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-26
- Primary completion
- 2027-03-20
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.